Prores (Biotechnology) Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.7M
Latest Deal Amount
  • Investors
  • 5

Prores (Biotechnology) General Information

Description

Developer of a eed incorporated preventative disease management technology designed to revolutionize the world of antibiotic discovery. The company's technology develops adaptive microbiome modulators by using chemical communications to spur Streptomyces bacteria, enabling researchers to optimize the production of novel antibiotics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
  • 140 Elliott Street
  • Building F
  • Beverly, MA 01915
  • United States
+1 (978) 000-0000

Prores (Biotechnology) Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prores (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 20-Mar-2019 $1.7M 00.000 00.00 Completed Generating Revenue
2. Seed Round 31-Jul-2017 00000 00000 00.000 Completed Startup
1. Accelerator/Incubator 15-Aug-2015 $100K $100K Completed Startup
To view Prores (Biotechnology)’s complete valuation and funding history, request access »

Prores (Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Prores (Biotechnology)’s complete cap table history, request access »

Prores (Biotechnology) Executive Team (4)

Name Title Board Seat Contact Info
Dakota Hamill Chief Executive Officer & Co-Founder
Jake Cotter Chief Operating Officer, President and Co-Founder
William Liao Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Prores (Biotechnology) Board Members (2)

Name Representing Role Since
Jake Cotter Prores (Biotechnology) Chief Operating Officer, President and Co-Founder 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Prores (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prores (Biotechnology) Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morningside Group Venture Capital Minority 000 0000 000000 0
HATCH (Consulting Services (B2B)) Accelerator/Incubator Minority 000 0000 000000 0
North Shore InnoVentures Accelerator/Incubator Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
RebelBio Accelerator/Incubator Minority 000 0000 000000 0
To view Prores (Biotechnology)’s complete investors history, request access »